טרסבה 100 מג
roche pharmaceuticals (israel) ltd - erlotinib - טבליות מצופות פילם - erlotinib 100 mg - erlotinib
טרסבה 100 מג
roche pharmaceuticals (israel) ltd - erlotinib - טבליות מצופות פילם - erlotinib 100 mg - erlotinib
טרסבה 150 מג
roche pharmaceuticals (israel) ltd - erlotinib - טבליות מצופות פילם - erlotinib 150 mg - erlotinib
טרסבה 150 מג
roche pharmaceuticals (israel) ltd - erlotinib - טבליות מצופות פילם - erlotinib 150 mg - erlotinib
קסופלוזה 20 מג
roche pharmaceuticals (israel) ltd - baloxavir marboxil - טבליות מצופות פילם - baloxavir marboxil 20 mg - baloxavir marboxil
קסופלוזה 40 מג
roche pharmaceuticals (israel) ltd - baloxavir marboxil - טבליות מצופות פילם - baloxavir marboxil 40 mg - baloxavir marboxil
גברטו
roche pharmaceuticals (israel) ltd - pralsetinib - קפסולה קשיחה - pralsetinib 100 mg - pralsetinib
ואביסמו
roche pharmaceuticals (israel) ltd - faricimab - תמיסה להזרקה - faricimab 120 mg/ml - faricimab
electrochemical oxygen sensors, analyzers, monitors and air/ oxygen blenders
עינת מדיקל סוכנויות בע"מ - ניטור חמצן
רקורמון 2000 iu
roche pharmaceuticals (israel) ltd - epoetin beta 2000 iu / 0.3 ml - solution for injection - erythropoietin - treatment of anemia associated with chronic renal failure (renal anemia) in patients on dialysis. treatment of symptomatic renal anemia in patients not yet undergoing dialysis. increasing the yield of autologous blood from patients in a pre-donation program. its use in this indication must be balanced against the reported increased risk of thromboembolic events. treatment should only be given to patients with moderate anemia (hb 10-13 g/dl (6.21- 8.07 mmol/l) no iron deficiency) or when blood conserving procedures are not available or insufficient when the scheduled major elective surgery requires a large volume of blood (4 or more units of blood for females or 5 or more units for males). treatment of anemia in adult patients with solid tumors and treated with platinum-based chemotherapy prone to induce anemia (cisplatin 75 mg/m2/cycle carboplatin: 350 mg/m2/cycle). treatment of anemia in adult patients with multiple myeloma low grade non-hodgkin's lymphoma or chronic lymphocytic leukemia who have a relative